FDA Clearance Tracker · P200032
Occlutech® ASD Occluder and Occlutech® Pistol Pusher
Last checked: Nov 20, 2026Latest source record: Dec 29, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Dec 29, 2023
Approved
Time to decision
1,270 days
Received Jul 7, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P200032
- Device name
- Occlutech® ASD Occluder and Occlutech® Pistol Pusher
- Applicant
- Occlutech Holding AG
- Applicant location
- Schaffhausen
- Received
- Jul 7, 2020
- Decided
- Dec 29, 2023
- Decision
- Approved
- Supplements
- 6 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Transcatheter septal occluder (atrial) (OZG)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
The Occlutech ASD Occluder is a medical device intended for transcatheter closure of ostium secundum-type atrial septal defects (ASD). Patients indicated for ASD closure have: Echocardiographic evidence of ostium secundum-type ASD, Clinical evidence of right ventricular (RV) volume overload (hemodynamically significant left-to-right shunt with Qp / Qs ? 1.5 or RV enlargement).The Occlutech Pistol Pusher is a percutaneous, transcatheter pusher system designed for the delivery of the Occlutech ASD Occluder to the implantation area. It is used via a minimally invasive catheter delivery system technique.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code OZG (Transcatheter septal occluder (atrial)).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Occlutech Holding AG
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.